A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Big deal: NMD series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
The Johns Hopkins spinout will funnel the cash into developing a class of glutamine antagonist that could help treat cancer.
Renephra lances $327,000 round
The transdermal fluid removal spinout will aim for a close of at least $426,000 with another $99,400 from private investors.
Nanosatellite internet of things technology developer Myriota has attracted $15m in series A funding from investors co-led by Main Sequence Ventures.
Minnesota opens medtech accelerator
Snoring, asthma and cardiac arrest are all on the agenda of companies in University of Minnesota’s accelerator.
Frontier IP’s portfolio value soars 49%
The commercialisation firm’s portfolio is now worth $11.3m after a series of successes for its early-stage investees.
CTT touches on Parkwalk investment
Parkwalk has invested from two vehicles under its management after previously backing the Cambridge spinout in late 2016.
Circular Wave coils together $2m seed round
The Ohio State spinout raised an additional $900,000 to advance its speed control gear technology for industrial robots.
Several existing shareholders including Woodford have returned to back a $17m funding round for Metalysis, which produces metal powders for 3D printing.
Vanderbilt to benefit from $65m partnership
Deerfield Management and Vanderbilt University have launched Ancora Innovation with $65m in capital to support early-stage life science research and back resulting spinouts.
Symbiotix secures Harvard licences
Symbiotix has licensed more Harvard IP to propel the commercialisation of T-cell modulators based on studies of the human microbiome.